A management powerhouse has come on board at Innovative Medical Device Solutions (IMDS). The company has announced that Brady R. Shirley, former Senior VP of Stryker Endoscopy and President of Stryker Communications, will be its new President and Chief Executive Officer.
Brady Shirley: New President, CEO at IMDS
2 min read Premium comments
IMDS, which focuses on the orthopedic industry, is known for its comprehensive product development, manufacturing and supply chain management solutions for medical device companies.
Shirley, who has been at Stryker Corporation for the last 17 years in a range of general management, sales and marketing roles, has contributed directly to strong annual revenue growth and innovation in the divisions he served.
Wade Fallin, IMDS’ former President and CEO and continuing board member, said that the IMDS board unanimously selected Shirley based on his track record leading a complex organization, as well as his strong executive and personal qualities.
“Shirley came to our attention because of his strong execution skills, his proven ability to lead top performing teams and his track record in driving shareholder value, particularly through innovation, ” said Fallin in the news release. “Additionally, his straightforward style and exceptional people skills are a perfect fit with the IMDS culture that serves our employees, partners and investors so well.”
In the news release, Shirley stated, “I am excited about the IMDS of today and tomorrow based on the strategic growth of our Product Sourcing capabilities and a continued strengthening of an already best-in-market Co-Innovation business. IMDS is well positioned to be the leading source of innovation for our strategic OEM partners and we will deliver on that promise. “
Regarding the strategic growth, Shirley told OTW,
In other words, instead of simply acquiring companies to expand IMDS, we are uniquely positioned to grow by combining our world class product development capabilities with key innovative manufacturing capabilities to provide a Strategic Sourcing Partner for our customers. We can provide turn key solutions from idea to launch in less than 12 months vs. the typical 30 month cycle. We are positioned to grow revenue 25-30%+ per year over the next few years based on our unique Strategic Sourcing capability.
“Brady Shirley’s selection as President and CEO positions IMDS for our next phase of major growth. Brady’s medical device experience, energy, and customer focus will provide both our customers and stakeholders with exceptional value, ” said Harold Linville, IMDS Chairman of the Board, in the news release.
When asked about personal experiences that helped prepare him for this new role, Shirley commented to OTW,
While running Sales & Marketing for Stryker Endoscopy for the last 10 years I have had the opportunity to lead innovative product development across the orthopedic space as well as many other specialties…in doing so, I have many, many relationships with key opinion leaders as well as leaders within the orthopedic companies. From a pure leadership perspective, I helped grow one of Stryker’s largest divisions while pioneering a startup and growing it into a division. This ‘mix’ will provide experience to integrate our four service areas and lead a very good company on its way to being great.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.